Jinan DEXINJIA Biotechnology Co., Ltd., a high-tech enterprise located in Jinan and founded in 2006, conducts research and development, pilot scale production and distribution. It owns one R & D center, two pilot scale production shops and one production base. With its strong technical forces it was rated as one of the High-tech Enterprises in 2007. In 2008 with the help of several doctors graduated from Tsinghua University it incorporated its Technical R & D Center in Jinan which has accomplished the research and development of more than 50 customized products for domestic and overseas clients over the past year. DXJ is capable of mass production of such bulk drugs as Tiotropium Bromide, Dofetilide and Dextromethorphan Hydrochloride and intermediates including piperidine derivatives like Piperidine carboxylic acids, Piperidine methanol, Methyl (Ethyl) Piperidine carboxylate and piperidine carboxyaldehyde and pyridine derivatives like Picolinic acids and Pyridylaldehyde. DXJ has obtained the rights of import and export trade and its products are mainly for export. Currently, it has entered into stable business relations with many countries and regions, such as the United States, Europe, India, Korea, South America, Japan and Egypt, just to name a few. Relying on its strong technical forces, it constantly develops and steadily supplies quality products, catering to customers all over the world.
Product Categories
Jinan DEXINJIA Biotechnology Co., Ltd., a high-tech enterprise located in Jinan and founded in 2006, conducts research and development, pilot scale production and distribution. It owns one R & D center, two pilot scale production shops and one production base. With its strong technical forces it was rated as one of the High-tech Enterprises in 2007. In 2008 with the help of several doctors graduated from Tsinghua University it incorporated its Technical R & D Center in Jinan which has accomplished the research and development of more than 50 customized products for domestic and overseas clients over the past year. DXJ is capable of mass production of such bulk drugs as Tiotropium Bromide, Dofetilide and Dextromethorphan Hydrochloride and intermediates including piperidine derivatives like Piperidine carboxylic acids, Piperidine methanol, Methyl (Ethyl) Piperidine carboxylate and piperidine carboxyaldehyde and pyridine derivatives like Picolinic acids and Pyridylaldehyde. DXJ has obtained the rights of import and export trade and its products are mainly for export. Currently, it has entered into stable business relations with many countries and regions, such as the United States, Europe, India, Korea, South America, Japan and Egypt, just to name a few. Relying on its strong technical forces, it constantly develops and steadily supplies quality products, catering to customers all over the world.